Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Classical hematology 1

Conditions

Head and Neck Neoplasms 2095 Squamous Cell Carcinoma of Head and Neck 1649 Nasopharyngeal Carcinoma 517 Thyroid Neoplasms 477 Carcinoma, Non-Small-Cell Lung 435 Breast Neoplasms 314 Mouth Neoplasms 312 Neoplasms 309 Melanoma 299 Oropharyngeal Neoplasms 285 Colorectal Neoplasms 272 Lung Neoplasms 246 Carcinoma, Squamous Cell 239 Neoplasm Metastasis 235 Ovarian Neoplasms 226 Uterine Cervical Neoplasms 202 Stomach Neoplasms 195 Salivary Gland Neoplasms 192 Laryngeal Neoplasms 192 Nasopharyngeal Neoplasms 188 Carcinoma, Renal Cell 182 Esophageal Neoplasms 179 Pancreatic Neoplasms 176 Prostatic Neoplasms 157 Sarcoma 142 Urinary Bladder Neoplasms 135 Triple Negative Breast Neoplasms 134 Recurrence 127 Endometrial Neoplasms 123 Hypopharyngeal Neoplasms 121

Interventions

Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breakthrough Pain × Head & Neck × Clear all

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡